Mark Sleeman

Mark Sleeman

Company: Regeneron Pharmaceuticals

Job title: Vice President

Seminars:

Prioritizing Quality Over Quantity in Weight Loss: Strategies for Preserving Muscle Mass in Obesity Treatment 11:00 am

Explore innovative therapeutic approaches that focus on maintaining muscle mass during weight loss, with insights into Regeneron’s cutting-edge research on musclepreserving antibodies Understand the metabolic benefits of muscle preservation in obesity management, including the dual-targeting strategies used to block muscle degradation pathwaysRead more

day: Conference Day One

Panel & Audience Discussion: Challenging Standards & Driving Innovation in Obesity Therapeutics 8:00 am

This dynamic session merges critical evaluation of the current obesity treatment landscape with bold, forward-thinking discussions to redefine therapeutic goals and approaches. Benchmarking Current Therapies: Assessing therapeutic efficacy, gaps, and unmet patient needs to set new standards of care. Innovative Debates: Examining provocative questions, including: Does muscle loss matter if fat-to-lean mass ratios improve? Are…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.